|
|
41
|
0321AB
|
GENTAMICIN 40MG/ML IV/IM INJ (RTM) (B)
|
GENTAMICIN
|
GENTAMICIN
|
10X2ML
|
B
|
14.9
|
1.4896
|
AMP
|
0
|
BOX
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
081202
|
AMINOGLYCOSIDES
|
2024-04-01
|
2026-03-31
|
|
IV/IM
|
0
|
AMINOGLYCOSIDES
|
|
|
|
40
|
0321AX
|
GENTASHIP 40MG/ML IV/IM INJ (FSB/ATB) GENTAMI
|
GENTAMICIN
|
GENTASHIP
|
10X2ML
|
B
|
5.41
|
0.54
|
INJECTION
|
0
|
AMP
|
FSB
|
FLAGSHIP BIOTECH
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
081202
|
AMINOGLYCOSIDES
|
2022-04-01
|
2022-07-11
|
|
IV/IM
|
6
|
ANTI-INFECTIVE AGENTS
|
|
|
|
40
|
0321AX
|
GENTASHIP 40MG/ML IV/IM INJ (FSB/ATB) GENTAMI
|
GENTAMICIN
|
GENTASHIP
|
10X2ML
|
B
|
6.74
|
0.67
|
INJECTION
|
0
|
AMP
|
FSB
|
FLAGSHIP BIOTECH
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
081202
|
AMINOGLYCOSIDES
|
2022-07-12
|
2024-03-31
|
Price Change
|
IV/IM
|
6
|
ANTI-INFECTIVE AGENTS
|
2022-07-11
|
|
|
40
|
03248
|
GENOPTIC 0.3% EYE DR (ASL/PHA) GENTAMICIN
|
GENTAMICIN
|
GENOPTIC
|
5ML
|
BQ
|
4.08
|
4.08
|
EYE DROP
|
1
|
BOTT
|
ASL
|
ASHFORD LABORATORIES LTD
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
520404
|
EENT ANTIBACTERIALS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
41
|
03248
|
GENOPTIC 0.3% EYE DR (ASL) GENTAMICIN
|
GENTAMICIN
|
GENOPTIC
|
5ML
|
BQ
|
7.34
|
7.3395
|
BOTT
|
1
|
BOTT
|
ASL
|
ASHFORD LABORATORIES LTD
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
520404
|
EENT ANTIBACTERIALS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
0
|
EENT ANTIBACTERIALS
|
|
|
|
40
|
03267
|
GENTAMICIN 0.3% EYE OINT (AKI/AHI)
|
GENTAMICIN
|
GENTAMICIN
|
3.5G
|
C
|
156.87
|
156.87
|
EYE OINTMENT
|
0
|
TUBE
|
AKI
|
AKORN INC.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
520404
|
EENT ANTIBACTERIALS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
40
|
03628
|
ETHAMBUTOL 400MG TAB (MCP/AHI)
|
ETHAMBUTOL
|
ETHAMBUTOL
|
10X10
|
A
|
12.42
|
0.12
|
TABLET
|
150
|
TAB
|
MCP
|
MACLEODS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081604
|
ANTITUBERCULOSIS AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
ANTI-INFECTIVE AGENTS
|
|
|
|
41
|
03628
|
ETHAMBUTOL 400MG TAB (MCP)
|
ETHAMBUTOL
|
ETHAMBUTOL
|
10X10
|
A
|
18.62
|
0.1862
|
TAB
|
150
|
BOX
|
MCP
|
MACLEODS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
0816
|
ANTIMYCOBACTERIALS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTIMYCOBACTERIALS
|
|
|
|
40
|
0372B
|
ISONIAZID 300MG TAB (MCP/AHI)
|
ISONIAZID
|
ISONIAZID
|
10X10
|
A
|
8.37
|
0.08
|
TABLET
|
30
|
TAB
|
MCP
|
MACLEODS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081604
|
ANTITUBERCULOSIS AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
ANTI-INFECTIVE AGENTS
|
|
|
|
41
|
0372B
|
ISONIAZID 300MG TAB (MCP)
|
ISONIAZID
|
ISONIAZID
|
10X10
|
A
|
9.24
|
0.0924
|
TAB
|
30
|
BOX
|
MCP
|
MACLEODS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
0816
|
ANTIMYCOBACTERIALS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTIMYCOBACTERIALS
|
|
|
|
40
|
0373E
|
ISONIAZID 100MG TAB (MCP/AHI)
|
ISONIAZID
|
ISONIAZID
|
10X10
|
A
|
5.55
|
0.06
|
TABLET
|
30
|
TAB
|
MCP
|
MACLEODS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081604
|
ANTITUBERCULOSIS AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
ANTI-INFECTIVE AGENTS
|
|
|
|
41
|
0373E
|
ISONIAZID 100MG TAB (MCP)
|
ISONIAZID
|
ISONIAZID
|
10X10
|
A
|
6.25
|
0.0625
|
TAB
|
30
|
BOX
|
MCP
|
MACLEODS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
0816
|
ANTIMYCOBACTERIALS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTIMYCOBACTERIALS
|
|
|
|
40
|
0381Q
|
RIFAMPICIN 300MG CAP (MCP/AHI)
|
RIFAMPICIN
|
RIFAMPICIN
|
10X10
|
A
|
68.96
|
0.69
|
CAPSULE
|
60
|
CAP
|
MCP
|
MACLEODS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081604
|
ANTITUBERCULOSIS AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
ANTI-INFECTIVE AGENTS
|
|
|
|
40
|
0383J
|
RIFAMPICIN 150MG CAP (MCP/AHI)
|
RIFAMPICIN
|
RIFAMPICIN
|
10X10
|
A
|
41.78
|
0.42
|
CAPSULE
|
120
|
CAP
|
MCP
|
MACLEODS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081604
|
ANTITUBERCULOSIS AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
ANTI-INFECTIVE AGENTS
|
|
|
|
40
|
0411J
|
CHLOROQUINE SULPHATE 250MG TAB (HEA/RXP)
|
CHLOROQUINE SULPHATE
|
CHLOROQUINE SULPHATE
|
40'S
|
A
|
24.33
|
0.61
|
TABLET
|
90
|
TAB
|
HEA
|
HEALTH 2000 INC
|
RXP
|
RX PRO INC
|
|
083008
|
ANTIMALARIALS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
ANTI-INFECTIVE AGENTS
|
|
|
|
40
|
0411K
|
CHLOROQUINE SULPHATE 250MG TAB (HEA/ATB)
|
CHLOROQUINE SULPHATE
|
CHLOROQUINE SULPHATE
|
40'S
|
A
|
24.33
|
0.6082
|
TABLET IMMED
|
90
|
|
HEA
|
HEALTH 2000 INC
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
83008
|
ANTIMALARIALS
|
2022-07-12
|
|
la
|
oral
|
6
|
ANTIMALARIALS
|
|
|
|
40
|
0411K
|
CHLOROQUINE SULPHATE 250MG TAB (HEA/ATB)
|
CHLOROQUINE SULPHATE
|
CHLOROQUINE SULPHATE
|
40'S
|
A
|
24.33
|
0.6082
|
TABLET IMMED
|
|
|
HEA
|
HEALTH 2000 INC
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
83008
|
ANTIMALARIALS
|
2022-12-07
|
2024-03-31
|
Change Local Agent
|
oral
|
6
|
ANTIMALARIALS
|
2022-11-25
|
|
|
40
|
04219
|
PRIMAQUINE PHOSPHATE 15MG TAB (KWA/ATB)
|
PRIMAQUINE PHOSPHATE
|
PRIMAQUINE PHOSPHATE
|
3X10
|
A
|
40.77
|
1.36
|
TABLET
|
90
|
TAB
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
083008
|
ANTIMALARIALS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
ANTI-INFECTIVE AGENTS
|
|
|
|
41
|
0441L
|
QUININE SULPHATE 300MG TAB (STP)
|
QUININE SULPHATE
|
QUININE SULPHATE
|
1000'S
|
A
|
258.24
|
0.2582
|
TAB
|
42
|
BOX
|
STP
|
STEROP LABORATORIES
|
COL
|
COLLINS LTD
|
|
083008
|
ANTIMALARIALS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTIMALARIALS
|
|
|
|
40
|
0451A
|
CO-TRIMOXAZOLE 400MG | 80MG TAB (HEA/RXP) SULFA
|
SULFAMETHOXAZOLE|TRIMETHOPRIM
|
CO-TRIMOXAZOLE
|
10X10
|
A
|
7.20
|
0.07
|
TABLET
|
56
|
TAB
|
HEA
|
HEALTH 2000 INC
|
RXP
|
RX PRO INC
|
|
081220
|
SULPHONAMIDES
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|